Skip to main content
Caplight Logo









Noble Biomaterials, Inc.

Noble Biomaterials, Inc.

Private
Scranton, PennsylvaniaFrontier & Industrial Techhttps://noblebiomaterials.com/

Last Round

Debt

Aug 18, 2022

Total Funding Raised

$8.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Noble Biomaterials, Inc. is a materials science company that develops, manufactures, and markets antimicrobial and conductive technologies for applications in the performance apparel, healthcare, industrial, and military markets.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Medical Devices, Sensors, Sports & Fitness, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial textilessilver-based technologyconductive fiberssmart textilese-textilesmaterial sciencemedical textilesperformance apparelwearable sensorsingredient brandantimicrobial coatingsdefense materialstextile engineeringwearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Noble Biomaterials, Inc. Comparables

Compare Noble Biomaterials, Inc. with similar companies based on industry and business-model similarity.

Noble Biomaterials, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sciessent
86%
PurThread Technologies
81%
Heiq PLC
80%

Noble Biomaterials, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtAug 18, 2022
DebtOct 18, 2021
Series BFeb 10, 2012

Key People

Founding team and executive leadership

Joel Furey

Founder Chief Commercial Officer, Member, Board Of Directors

Founding Team

Jeff Keane

Chief Executive Officer

Executive Team

pierangelo venturi

CEO

Executive Team

pierangelo Venturi

CEO

Executive Team

Noble Biomaterials, Inc. Investors

Notable investors and investment history

Noble Biomaterials, Inc. investors
InvestorRounds
Northwater Capital ManagementSeries B
Benjamin Franklin Technology PartnersDebt
TL VenturesSeries B
DuPont Capital ManagementSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 54% MoM, reaching 2.3K.

  • Jan 20, 2026

    Attending the 2026 PGA Show to showcase material technologies.

Noble Biomaterials, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Noble Biomaterials, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Noble Biomaterials, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersScranton, Pennsylvania
Employee Range59
Year Founded1997
Last FundingAug 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?